{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T01:14:59Z","timestamp":1788052499342,"version":"build-2784847793"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W023768\/1"],"award-info":[{"award-number":["MR\/W023768\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119216","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:23:53Z","timestamp":1786033433000},"page":"119216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of uracil-based antagonists and fluorescent ligands of the P2Y2 receptor"],"prefix":"10.1016","volume":"318","author":[{"given":"Mahesh","family":"Puthanveedu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5339-5382","authenticated-orcid":false,"given":"Eleonora","family":"Comeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas D.","family":"Kindon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barrie","family":"Kellam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Kilpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4424-239X","authenticated-orcid":false,"given":"Stephen J.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Stocks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2026.119216_bib1","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/j.1476-5381.1995.tb16382.x","article-title":"Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate","volume":"116","author":"Lazarowski","year":"1995","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119216_bib2","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/bph.15005","article-title":"Update of P2Y receptor pharmacology: IUPHAR review 27","volume":"177","author":"Jacobson","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"22","key":"10.1016\/j.ejmech.2026.119216_bib3","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1021\/jm049914c","article-title":"Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling","volume":"47","author":"Costanzi","year":"2004","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119216_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/pr.58.3.3","article-title":"International union of pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy","volume":"58","author":"Abbracchio","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119216_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41421-025-00797-x","article-title":"Structural insight into the self-activation and G-protein coupling of P2Y2 receptor","volume":"11","author":"Lan","year":"2025","journal-title":"Cell Discov."},{"issue":"1\u20133","key":"10.1016\/j.ejmech.2026.119216_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0167-4781(01)00291-3","article-title":"Expression pattern of human P2Y receptor subtypes: a quantitative reverse transcription-polymerase chain reaction study","volume":"1521","author":"Moore","year":"2001","journal-title":"Biochim. Biophys. Acta Gene Struct. Expr."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119216_bib7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/pro.3987","article-title":"The human protein atlas\u2014spatial localization of the human proteome in health and disease","volume":"30","author":"Digre","year":"2021","journal-title":"Protein Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119216_bib8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11302-022-09900-3","article-title":"Therapeutic potential for P2Y2 receptor antagonism","volume":"19","author":"Jasmer","year":"2023","journal-title":"Purinergic Signal."},{"issue":"22","key":"10.1016\/j.ejmech.2026.119216_bib9","doi-asserted-by":"crossref","first-page":"35962","DOI":"10.18632\/oncotarget.16414","article-title":"The purinergic receptor subtype P2Y2 mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung disease","volume":"8","author":"M\u00fcller","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.ejmech.2026.119216_bib10","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/ATVBAHA.115.307397","article-title":"Extracellular ATP induces vascular inflammation and atherosclerosis via purinergic receptor Y2 in mice","volume":"36","author":"Stachon","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119216_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/ATVBAHA.116.308561","article-title":"Endothelial cell\u2013specific deletion of P2Y2 receptor promotes plaque stability in atherosclerosis-susceptible ApoE-Null mice","volume":"37","author":"Chen","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejmech.2026.119216_bib12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.atherosclerosis.2016.07.927","article-title":"The P2Y2 receptor mediates uptake of matrix-retained and aggregated low density lipoprotein in primary vascular smooth muscle cells","volume":"252","author":"Dissmore","year":"2016","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119216_bib13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ccr.2013.05.008","article-title":"Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor","volume":"24","author":"Schumacher","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2026.119216_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104808","article-title":"P2Y2 receptors mediate nucleotide-induced EGFR phosphorylation and stimulate proliferation and tumorigenesis of head and neck squamous cell carcinoma cell lines","volume":"109","author":"Woods","year":"2020","journal-title":"Oral Oncol."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119216_bib15","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/bjc.2013.484","article-title":"P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells","volume":"109","author":"Li","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119216_bib16","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1158\/1078-0432.CCR-18-2297","article-title":"Targeting purinergic receptor P2Y2 prevents the growth of pancreatic ductal adenocarcinoma by inhibiting cancer cell glycolysis","volume":"25","author":"Hu","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119216_bib17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1158\/0008-5472.CAN-19-1909","article-title":"Extracellular ATP and purinergic P2Y2 receptor signaling promote liver tumorigenesis in mice by exacerbating DNA damage","volume":"80","author":"Schulien","year":"2020","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119216_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11302-009-9151-5","article-title":"P2Y2 receptors and water transport in the kidney","volume":"5","author":"Kishore","year":"2009","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.ejmech.2026.119216_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101089","article-title":"P2Y2R contributes to the development of diabetic nephropathy by inhibiting autophagy response","volume":"42","author":"Dusabimana","year":"2020","journal-title":"Mol. Metabol."},{"issue":"23","key":"10.1016\/j.ejmech.2026.119216_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312563","article-title":"Activation of purinergic P2Y2 receptor protects the kidney against renal ischemia and reperfusion injury in mice","volume":"25","author":"Jeong","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119216_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2013.00234","article-title":"P2Y2 receptor deficiency aggravates chronic kidney disease progression","volume":"4","author":"Potthoff","year":"2013","journal-title":"Front. Physiol."},{"issue":"14","key":"10.1016\/j.ejmech.2026.119216_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167704","article-title":"P2Y2 receptor decreases blood pressure by inhibiting ENaC","volume":"8","author":"Soares","year":"2023","journal-title":"JCI Insight"},{"issue":"22","key":"10.1016\/j.ejmech.2026.119216_bib23","doi-asserted-by":"crossref","first-page":"9981","DOI":"10.1021\/acs.jmedchem.5b01972","article-title":"Drug-like antagonists of P2Y receptors\u2014from lead identification to drug development","volume":"59","author":"Conroy","year":"2016","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119216_bib24","doi-asserted-by":"crossref","first-page":"9057","DOI":"10.1021\/acs.jmedchem.5c00249","article-title":"Drug-like antagonists of P2Y receptor subtypes: an update","volume":"68","author":"Puthanveedu","year":"2025","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2026.119216_bib25","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1016\/j.bmcl.2017.09.043","article-title":"From UTP to AR-C118925, the discovery of a potent non nucleotide antagonist of the P2Y2 receptor","volume":"27","author":"Kindon","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119216_bib26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11302-016-9542-3","article-title":"Synthesis, characterization, and in vitro evaluation of the selective P2Y2 receptor antagonist AR-C118925","volume":"13","author":"Rafehi","year":"2017","journal-title":"Purinergic Signal."},{"issue":"13","key":"10.1016\/j.ejmech.2026.119216_bib27","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1113\/JP274731","article-title":"Purinergic receptor stimulation induces calcium oscillations and smooth muscle contraction in small pulmonary veins","volume":"596","author":"Henriquez","year":"2018","journal-title":"J. Physiol. (Lond.)"},{"key":"10.1016\/j.ejmech.2026.119216_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104808","article-title":"P2Y2 receptors mediate nucleotide-induced EGFR phosphorylation and stimulate proliferation and tumorigenesis of head and neck squamous cell carcinoma cell lines","volume":"109","author":"Woods","year":"2020","journal-title":"Oral Oncol."},{"key":"10.1016\/j.ejmech.2026.119216_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111789","article-title":"Design, synthesis and biological evaluation of suramin-derived dual antagonists of the proinflammatory G protein-coupled receptors P2Y2 and GPR17","volume":"186","author":"Pillaiyar","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119216_bib31","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1021\/acs.jcim.1c01235","article-title":"Discovery of P2Y2 receptor antagonist scaffolds through virtual high-throughput screening","volume":"62","author":"Neumann","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.119216_bib32","doi-asserted-by":"crossref","DOI":"10.1021\/acsmedchemlett.4c00211","article-title":"Design, synthesis, and evaluation of a new chemotype fluorescent ligand for the P2Y2 receptor","author":"Knight","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119216_bib33","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1021\/acs.jmedchem.8b00139","article-title":"Synthesis and evaluation of the first fluorescent antagonists of the human P2Y2 receptor based on AR-C118925","volume":"61","author":"Conroy","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119216_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pharmthera.2018.04.002","article-title":"Tools and drugs for uracil nucleotide-activated P2Y receptors","volume":"190","author":"Rafehi","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2026.119216_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118335","article-title":"From tetrazole to isoquinolinone: structure-based optimization and late-stage diversification of AR-C118925-derived P2Y2 receptor antagonists","volume":"302","author":"Abdalrahman","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119216_bib35","series-title":"Stephen Thom. NOVEL COMPOUNDS","author":"Nicholas Kindon","year":"1999"},{"issue":"5","key":"10.1016\/j.ejmech.2026.119216_bib36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1021\/jo00919a001","article-title":"Reaction of pyrimidines with diarylmethyl cations","volume":"39","author":"Whitehead","year":"1974","journal-title":"J. Org. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119216_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119216_bib38","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cmdc.200700139","article-title":"Lessons learnt from assembling screening libraries for drug discovery for neglected diseases","volume":"3","author":"Brenk","year":"2008","journal-title":"ChemMedChem"},{"issue":"20","key":"10.1016\/j.ejmech.2026.119216_bib39","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1021\/acs.jmedchem.7b00854","article-title":"Molecular recognition of agonists and antagonists by the nucleotide-activated G protein-coupled P2Y2 receptor","volume":"60","author":"Rafehi","year":"2017","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119216_bib40","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/ci100031x","article-title":"Conformer generation with OMEGA: algorithm and validation using high quality structures from the protein databank and Cambridge structural database","volume":"50","author":"Hawkins","year":"2010","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119216_bib41","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1021\/ci100436p","article-title":"FRED pose prediction and virtual screening accuracy","volume":"51","author":"McGann","year":"2011","journal-title":"J. Chem. Inf. Model."},{"issue":"8","key":"10.1016\/j.ejmech.2026.119216_bib42","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10822-012-9584-8","article-title":"FRED and HYBRID docking performance on standardized datasets","volume":"26","author":"McGann","year":"2012","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119216_bib43","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tips.2017.10.006","article-title":"NanoBRET approaches to study ligand binding to GPCRs and RTKs","volume":"39","author":"Stoddart","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119216_bib44","article-title":"Small molecule tools to study cellular target engagement for the intracellular allosteric binding site of GPCRs","volume":"29","author":"Huber","year":"2023","journal-title":"Chem. Eur J."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119216_bib45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11302-019-09650-9","article-title":"A live cell NanoBRET binding assay allows the study of ligand-binding kinetics to the adenosine A3 receptor","volume":"15","author":"Bouzo-Lorenzo","year":"2019","journal-title":"Purinergic Signal."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:23:19Z","timestamp":1788049399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426006616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":45,"alternative-id":["S0223523426006616"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119216","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of uracil-based antagonists and fluorescent ligands of the P2Y2 receptor","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119216"}}